Hsp90 inhibition suppresses mutant EGFR-T790M signaling and overcomes kinase inhibitor resistance

10.1158/0008-5472.CAN-07-5428

Saved in:
Bibliographic Details
Main Authors: Shimamura, T, Li, D, Ji, H, Haringsma, H.J, Liniker, E, Borgman, C.L, Lowell, A.M, Minami, Y, McNamara, K, Perera, S.A, Zaghlul, S, Thomas, R.K, Greulich, H, Kobayashi, S, Chirieac, L.R, Padera, R.F, Kubo, S, Takahashi, M, Tenen, D.G, Meyerson, M, Wong, K.-K, Shapiro, G.I
Other Authors: MEDICINE
Format: Article
Published: 2020
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/181021
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-181021
record_format dspace
spelling sg-nus-scholar.10635-1810212024-11-08T21:07:51Z Hsp90 inhibition suppresses mutant EGFR-T790M signaling and overcomes kinase inhibitor resistance Shimamura, T Li, D Ji, H Haringsma, H.J Liniker, E Borgman, C.L Lowell, A.M Minami, Y McNamara, K Perera, S.A Zaghlul, S Thomas, R.K Greulich, H Kobayashi, S Chirieac, L.R Padera, R.F Kubo, S Takahashi, M Tenen, D.G Meyerson, M Wong, K.-K Shapiro, G.I MEDICINE 17 demethoxy 17 (2 dimethylaminoethylamino)geldanamycin 3 bromo 5 tert butyl 4 hydroxybenzylidenemalononitrile 4 [3 chloro 4 (2 pyridinylmethoxy)anilino] 3 cyano 6 (4 dimethylaminocrotonamido) 7 ethoxyquinoline cl 387785 epidermal growth factor epidermal growth factor receptor kinase inhibitor erlotinib gefitinib heat shock protein 90 heat shock protein 90 inhibitor protein tyrosine kinase rapamycin tanespimycin unclassified drug antineoplastic agent enzyme inhibitor epidermal growth factor receptor heat shock protein 90 mammalian target of rapamycin protein kinase article cancer cell culture cancer resistance cytotoxicity drug inhibition human immunohistochemistry lung non small cell cancer mutational analysis priority journal protein expression protein phosphorylation adenocarcinoma animal apoptosis drug resistance gene expression regulation genetics lung tumor metabolism mouse mutation pathology signal transduction tumor cell line Adenocarcinoma Animals Antineoplastic Agents Apoptosis Cell Line, Tumor Drug Resistance, Neoplasm Enzyme Inhibitors Gene Expression Regulation, Neoplastic HSP90 Heat-Shock Proteins Lung Neoplasms Mice Mutation Protein Kinases Receptor, Epidermal Growth Factor Signal Transduction 10.1158/0008-5472.CAN-07-5428 Cancer Research 68 14 5827-5838 2020-10-27T06:55:55Z 2020-10-27T06:55:55Z 2008 Article Shimamura, T, Li, D, Ji, H, Haringsma, H.J, Liniker, E, Borgman, C.L, Lowell, A.M, Minami, Y, McNamara, K, Perera, S.A, Zaghlul, S, Thomas, R.K, Greulich, H, Kobayashi, S, Chirieac, L.R, Padera, R.F, Kubo, S, Takahashi, M, Tenen, D.G, Meyerson, M, Wong, K.-K, Shapiro, G.I (2008). Hsp90 inhibition suppresses mutant EGFR-T790M signaling and overcomes kinase inhibitor resistance. Cancer Research 68 (14) : 5827-5838. ScholarBank@NUS Repository. https://doi.org/10.1158/0008-5472.CAN-07-5428 00085472 https://scholarbank.nus.edu.sg/handle/10635/181021 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20201031
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic 17 demethoxy 17 (2 dimethylaminoethylamino)geldanamycin
3 bromo 5 tert butyl 4 hydroxybenzylidenemalononitrile
4 [3 chloro 4 (2 pyridinylmethoxy)anilino] 3 cyano 6 (4 dimethylaminocrotonamido) 7 ethoxyquinoline
cl 387785
epidermal growth factor
epidermal growth factor receptor kinase inhibitor
erlotinib
gefitinib
heat shock protein 90
heat shock protein 90 inhibitor
protein tyrosine kinase
rapamycin
tanespimycin
unclassified drug
antineoplastic agent
enzyme inhibitor
epidermal growth factor receptor
heat shock protein 90
mammalian target of rapamycin
protein kinase
article
cancer cell culture
cancer resistance
cytotoxicity
drug inhibition
human
immunohistochemistry
lung non small cell cancer
mutational analysis
priority journal
protein expression
protein phosphorylation
adenocarcinoma
animal
apoptosis
drug resistance
gene expression regulation
genetics
lung tumor
metabolism
mouse
mutation
pathology
signal transduction
tumor cell line
Adenocarcinoma
Animals
Antineoplastic Agents
Apoptosis
Cell Line, Tumor
Drug Resistance, Neoplasm
Enzyme Inhibitors
Gene Expression Regulation, Neoplastic
HSP90 Heat-Shock Proteins
Lung Neoplasms
Mice
Mutation
Protein Kinases
Receptor, Epidermal Growth Factor
Signal Transduction
spellingShingle 17 demethoxy 17 (2 dimethylaminoethylamino)geldanamycin
3 bromo 5 tert butyl 4 hydroxybenzylidenemalononitrile
4 [3 chloro 4 (2 pyridinylmethoxy)anilino] 3 cyano 6 (4 dimethylaminocrotonamido) 7 ethoxyquinoline
cl 387785
epidermal growth factor
epidermal growth factor receptor kinase inhibitor
erlotinib
gefitinib
heat shock protein 90
heat shock protein 90 inhibitor
protein tyrosine kinase
rapamycin
tanespimycin
unclassified drug
antineoplastic agent
enzyme inhibitor
epidermal growth factor receptor
heat shock protein 90
mammalian target of rapamycin
protein kinase
article
cancer cell culture
cancer resistance
cytotoxicity
drug inhibition
human
immunohistochemistry
lung non small cell cancer
mutational analysis
priority journal
protein expression
protein phosphorylation
adenocarcinoma
animal
apoptosis
drug resistance
gene expression regulation
genetics
lung tumor
metabolism
mouse
mutation
pathology
signal transduction
tumor cell line
Adenocarcinoma
Animals
Antineoplastic Agents
Apoptosis
Cell Line, Tumor
Drug Resistance, Neoplasm
Enzyme Inhibitors
Gene Expression Regulation, Neoplastic
HSP90 Heat-Shock Proteins
Lung Neoplasms
Mice
Mutation
Protein Kinases
Receptor, Epidermal Growth Factor
Signal Transduction
Shimamura, T
Li, D
Ji, H
Haringsma, H.J
Liniker, E
Borgman, C.L
Lowell, A.M
Minami, Y
McNamara, K
Perera, S.A
Zaghlul, S
Thomas, R.K
Greulich, H
Kobayashi, S
Chirieac, L.R
Padera, R.F
Kubo, S
Takahashi, M
Tenen, D.G
Meyerson, M
Wong, K.-K
Shapiro, G.I
Hsp90 inhibition suppresses mutant EGFR-T790M signaling and overcomes kinase inhibitor resistance
description 10.1158/0008-5472.CAN-07-5428
author2 MEDICINE
author_facet MEDICINE
Shimamura, T
Li, D
Ji, H
Haringsma, H.J
Liniker, E
Borgman, C.L
Lowell, A.M
Minami, Y
McNamara, K
Perera, S.A
Zaghlul, S
Thomas, R.K
Greulich, H
Kobayashi, S
Chirieac, L.R
Padera, R.F
Kubo, S
Takahashi, M
Tenen, D.G
Meyerson, M
Wong, K.-K
Shapiro, G.I
format Article
author Shimamura, T
Li, D
Ji, H
Haringsma, H.J
Liniker, E
Borgman, C.L
Lowell, A.M
Minami, Y
McNamara, K
Perera, S.A
Zaghlul, S
Thomas, R.K
Greulich, H
Kobayashi, S
Chirieac, L.R
Padera, R.F
Kubo, S
Takahashi, M
Tenen, D.G
Meyerson, M
Wong, K.-K
Shapiro, G.I
author_sort Shimamura, T
title Hsp90 inhibition suppresses mutant EGFR-T790M signaling and overcomes kinase inhibitor resistance
title_short Hsp90 inhibition suppresses mutant EGFR-T790M signaling and overcomes kinase inhibitor resistance
title_full Hsp90 inhibition suppresses mutant EGFR-T790M signaling and overcomes kinase inhibitor resistance
title_fullStr Hsp90 inhibition suppresses mutant EGFR-T790M signaling and overcomes kinase inhibitor resistance
title_full_unstemmed Hsp90 inhibition suppresses mutant EGFR-T790M signaling and overcomes kinase inhibitor resistance
title_sort hsp90 inhibition suppresses mutant egfr-t790m signaling and overcomes kinase inhibitor resistance
publishDate 2020
url https://scholarbank.nus.edu.sg/handle/10635/181021
_version_ 1821204934444449792